Calloway Labs is a rapidly growing clinical toxicology laboratory based in the United States. Specializing in proprietary testing protocols, the company addresses crucial challenges encountered by drug treatment and medical professionals, including Substance Abuse Screening and Drug Therapy Compliance. Calloway Labs stands out for its embrace of the latest technology throughout the testing lifecycle, from Insta-Cups and high-volume screening to in-house GC/MS and MRO review. Notably, the company was among the first clinical labs to offer test results through the internet, incorporate a seamless Medical Review Officer (MRO) process, and quantify results for buprenorphine and oxycodone. Moreover, Calloway Labs collaborates with industry leaders to educate medical and treatment professionals on the latest developments in patient care and regulatory compliance. As of now, there is no information available regarding the company's founding date or recent investments and investors.
There is no investment information
No recent news or press coverage available for Calloway Labs.
We care about your data, and we'd love to use cookies make your experience better.
